PACIFIC: Overall survival with durvalumab versus placebo after chemoradiotherapy in stage III NSCLC
Authors
Raben, DFaivre-Finn, Corinne
Spigel, D
Daniel, D
Villegas, A
Vincente, D
Hui, R
Carpeno, J
Murakami, S
Paz-Ares, L
Ozguroglu, M
Kurata, T
Chiappori, A
Lee, K
de Wit, M
Poole, L
Wadsworth, C
Dennis, P
Antonia, S
Affiliation
University of Colorado Cancer Center, Aurora, COIssue Date
2018